Role of palliative chemotherapy and shift from anticancer therapy to palliative care in patients with advanced or recurrent breast cancer

Japanese Journal of Cancer and Chemotherapy

Volumn 37, Issue 1, 2010, Pages 65-69

  Yamaguchi, Yumi ^a   Ohro, Shoutaro ^a   Yamashiro, Yutaka ^a   Shibata, Shunsuke ^a   Ishiguro, Minoru ^a   Yurugi, Eiichi ^a   Nishidoi, Hideaki ^a   Kudo, Hirofumi ^a  

^a Tottori Red Cross Hospital   (Japan)

Author keywords

Anthracycline; Breast cancer; Palliative care; Palliative chemotherapy; Taxane

Indexed keywords

ANALGESIC AGENT; ANTHRACYCLINE DERIVATIVE; TAXANE DERIVATIVE;

ADVANCED CANCER; ARTICLE; BONE METASTASIS; BREAST CANCER; CANCER MORTALITY; CANCER PALLIATIVE THERAPY; CANCER SURVIVAL; CLINICAL ARTICLE; HOSPITALIZATION; HUMAN; OUTPATIENT CARE; RECURRENT CANCER; SURVIVAL TIME;

EID: 79960751619     PISSN: 03850684     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (8)

1. Hortobagyi GN: Treatment of Breast Cancer. N Engl J Med 339(14): 974-984, 1998.
2. (http://www.jccnb.net/)
3. Grothey A, Sargent D, Goldberg RM, et al: Survival of patients with advanced colorectal cancer improves with the availability of fluorouracil-leucovorin, irinotecan, and oxaliplatin in the course of treatment. J Clin Oncol 22 (7): 1209-1214, 2004. (Pubitemid 41079833)
4. Harrington KD, Sim FH, Enis JE, et al: Methylmethacrylate as adjunct in internal fixation of pathological fractures. Experience with three hundred and seventy five cases. J Bone Joint Surg Am 58(8): 1047-1055, 1976. (Pubitemid 8017455)
5. Fleisch H: Bisphosphonates in bone disease. From the laboratory to the patients. Academic Press, New York, 2000, pp 88-117.